Your browser doesn't support javascript.
loading
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes.
Martinez-Heras, Eloy; Solana, Elisabeth; Vivó, Francesc; Lopez-Soley, Elisabet; Calvi, Alberto; Alba-Arbalat, Salut; Schoonheim, Menno M; Strijbis, Eva M; Vrenken, Hugo; Barkhof, Frederik; Rocca, Maria A; Filippi, Massimo; Pagani, Elisabetta; Groppa, Sergiu; Fleischer, Vinzenz; Dineen, Robert A; Bellenberg, Barbara; Lukas, Carsten; Pareto, Deborah; Rovira, Alex; Sastre-Garriga, Jaume; Collorone, Sara; Prados, Ferran; Toosy, Ahmed; Ciccarelli, Olga; Saiz, Albert; Blanco, Yolanda; Llufriu, Sara.
Affiliation
  • Martinez-Heras E; Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Solana E; Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Vivó F; Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Lopez-Soley E; Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Calvi A; Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Alba-Arbalat S; Neuroimmunology and Multiple Sclerosis Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Schoonheim MM; MS Center Amsterdam, Anatomy and Neurosciences, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Strijbis EM; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Vrenken H; Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Barkhof F; Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Rocca MA; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK.
  • Filippi M; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Pagani E; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Groppa S; Vita-Salute San Raffaele University, Milano, Italy.
  • Fleischer V; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Dineen RA; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Bellenberg B; Vita-Salute San Raffaele University, Milano, Italy.
  • Lukas C; Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Pareto D; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Rovira A; Department of Neurology, Neurostimulation and Neuroimaging, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Sastre-Garriga J; Department of Neurology, Neurostimulation and Neuroimaging, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • Collorone S; Mental Health and Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK; and NIHR Nottingham Biomedical Research Centre, Nottingham, UK.
  • Prados F; Institute of Neuroradiology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Toosy A; Institute of Neuroradiology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Ciccarelli O; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital and Research Institute (VHIR), Barcelona, Spain.
  • Saiz A; Section of Neuroradiology, Department of Radiology, Vall d'Hebron University Hospital and Research Institute (VHIR), Barcelona, Spain.
  • Blanco Y; Neurology-Neuroimmunology Department, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Llufriu S; Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Science, University College of London, London, UK.
J Neurol Neurosurg Psychiatry ; 94(11): 916-923, 2023 11.
Article in En | MEDLINE | ID: mdl-37321841
ABSTRACT

BACKGROUND:

We aimed to describe the severity of the changes in brain diffusion-based connectivity as multiple sclerosis (MS) progresses and the microstructural characteristics of these networks that are associated with distinct MS phenotypes.

METHODS:

Clinical information and brain MRIs were collected from 221 healthy individuals and 823 people with MS at 8 MAGNIMS centres. The patients were divided into four clinical phenotypes clinically isolated syndrome, relapsing-remitting, secondary progressive and primary progressive. Advanced tractography methods were used to obtain connectivity matrices. Then, differences in whole-brain and nodal graph-derived measures, and in the fractional anisotropy of connections between groups were analysed. Support vector machine algorithms were used to classify groups.

RESULTS:

Clinically isolated syndrome and relapsing-remitting patients shared similar network changes relative to controls. However, most global and local network properties differed in secondary progressive patients compared with the other groups, with lower fractional anisotropy in most connections. Primary progressive participants had fewer differences in global and local graph measures compared with clinically isolated syndrome and relapsing-remitting patients, and reductions in fractional anisotropy were only evident for a few connections. The accuracy of support vector machine to discriminate patients from healthy controls based on connection was 81%, and ranged between 64% and 74% in distinguishing among the clinical phenotypes.

CONCLUSIONS:

In conclusion, brain connectivity is disrupted in MS and has differential patterns according to the phenotype. Secondary progressive is associated with more widespread changes in connectivity. Additionally, classification tasks can distinguish between MS types, with subcortical connections being the most important factor.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Demyelinating Diseases / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Demyelinating Diseases / Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Limits: Humans Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2023 Document type: Article